Table 2.
Patient | GI | FMPS % | FMBS % | |
---|---|---|---|---|
Group 1- OILS | 1 | 1.3 | 81 | 33 |
2 | 1.4 | 62.5 | 37 | |
3 | 1.3 | 88 | 34 | |
4 | 1.2 | 69 | 30 | |
| ||||
Group 2- CLX | 1 | 1.3 | 66 | 36 |
2 | 1.7 | 85 | 61 | |
3 | 1.8 | 80 | 78 | |
4 | 1.1 | 63 | 24 | |
| ||||
Group 3- TTO | 1 | 1.8 | 100 | 69 |
2 | 1.6 | 73 | 54 | |
3 | 2 | 100 | 77 | |
4 | 1.7 | 65 | 60 | |
| ||||
Group 4 - Placebo | 1 | 1.6 | 68 | 64 |
2 | 1.6 | 55 | 63 | |
3 | 1.7 | 88 | 60 | |
4 | 1.4 | 82 | 45 |